TENAX THERAPEUTICS, INC. Fair Value Assumptions, Expected Volatility Rate (Deprecated 2018-01-31)
TENAX THERAPEUTICS, INC. (TENX) reported Fair Value Assumptions, Expected Volatility Rate (Deprecated 2018-01-31) of 90.00% for the 3-month period ending 2018-03-31, per its 10-Q filed 2018-05-15.
Discontinued › Notes › Fair Value Measures and Disclosures
us-gaap:FairValueAssumptionsExpectedVolatilityRate · last filed 2018-05-15
- TENAX THERAPEUTICS, INC. fair value assumptions, expected volatility rate (deprecated 2018-01-31) for the quarter ending 2018-03-31 was 90.00%, a 9.21% increase year-over-year.
- TENAX THERAPEUTICS, INC. fair value assumptions, expected volatility rate (deprecated 2018-01-31) for the quarter ending 2017-03-31 was 82.41%, a 7.07% decline year-over-year.
- TENAX THERAPEUTICS, INC. fair value assumptions, expected volatility rate (deprecated 2018-01-31) for the quarter ending 2016-03-31 was 88.68%.
- TENAX THERAPEUTICS, INC. fair value assumptions, expected volatility rate (deprecated 2018-01-31) for the quarter ending 2015-07-31 was 79.98%, a 10.08% decline year-over-year.
- TENAX THERAPEUTICS, INC. fair value assumptions, expected volatility rate (deprecated 2018-01-31) for fiscal 2016 was 79.60%, a 5.33% decline from fiscal 2015.
- TENAX THERAPEUTICS, INC. fair value assumptions, expected volatility rate (deprecated 2018-01-31) for fiscal 2015 was 84.08%.
- TENAX THERAPEUTICS, INC. fair value assumptions, expected volatility rate (deprecated 2018-01-31) for fiscal 2015 was 83.53%, a 7.52% decline from fiscal 2014.
- TENAX THERAPEUTICS, INC. fair value assumptions, expected volatility rate (deprecated 2018-01-31) for fiscal 2014 was 90.32%.
| Period end | Fair Value Assumptions, Expected Volatility Rate (Deprecated 2018-01-31) 3 month | Fair Value Assumptions, Expected Volatility Rate (Deprecated 2018-01-31) 6 month | Fair Value Assumptions, Expected Volatility Rate (Deprecated 2018-01-31) 8 month | Fair Value Assumptions, Expected Volatility Rate (Deprecated 2018-01-31) 9 month | Fair Value Assumptions, Expected Volatility Rate (Deprecated 2018-01-31) 12 month |
|---|---|---|---|---|---|
| 2018-03-31 | 90.00% 10-Q · filed 2018-05-15 | ||||
| 2017-12-31 | 81.26% 10-Q · filed 2018-05-15 | ||||
| 2017-09-30 | 84.53% 10-Q · filed 2017-11-09 | ||||
| 2017-06-30 | 83.20% 10-Q · filed 2017-08-09 | ||||
| 2017-03-31 | 82.41% 10-Q · filed 2017-05-10 | ||||
| 2016-12-31 | 79.60% 10-K · filed 2018-04-02 | ||||
| 2016-09-30 | 85.07% 10-Q · filed 2016-11-09 | ||||
| 2016-06-30 | 86.81% 10-Q · filed 2016-08-09 | ||||
| 2016-03-31 | 88.68% 10-Q · filed 2016-05-10 | ||||
| 2015-12-31 | 84.08% 10-KT · filed 2016-03-14 | 84.08% 10-K · filed 2017-03-16 | |||
| 2015-10-31 | 82.09% 10-Q · filed 2015-12-10 | ||||
| 2015-07-31 | 79.98% 10-Q · filed 2015-09-09 | ||||
| 2015-04-30 | 83.53% 10-KT · filed 2016-03-14 | ||||
| 2015-01-31 | 84.24% 10-Q · filed 2015-03-17 | ||||
| 2014-10-31 | 86.80% 10-Q · filed 2014-12-15 | ||||
| 2014-07-31 | 88.95% 10-Q · filed 2014-09-15 | ||||
| 2014-04-30 | 90.32% 10-KT · filed 2016-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Lunai Bioworks Inc. (LNAI) | United States | $0.072B | -0.11 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |